An antibody-drug conjugate used in selected urothelial cancer regimens.
Profile scope: Enfortumab vedotin-ejfv injection. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Fatigue, nausea, bowel changes, appetite loss, dry skin and hair loss may occur.
Serious risks and warning signs
A boxed warning addresses potentially fatal skin reactions. Severe high blood sugar, lung inflammation, nerve injury and eye problems are additional concerns. Blistering skin, marked thirst with vomiting, new breathing trouble or visual changes needs urgent oncology advice.
A question for your healthcare team
How will skin, glucose, nerve and eye symptoms be monitored, especially with combination treatment?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.